Clinical trial
Combined Treatment of Cetuximab and Paclitaxel in Basal Like Breast Carcinoma
NCT00353717 · Hadassah Medical Organization, Other · Unknown status
Key facts
| NCT number | NCT00353717 |
|---|---|
| Title | Combined Treatment of Cetuximab and Paclitaxel in Basal Like Breast Carcinoma |
| Official title | Phase II of Combined Treatment of Cetuximab and Paclitaxel in Basal Like Breast Carcinoma |
| Lead sponsor | Hadassah Medical Organization, Other |
| Status | Unknown status |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Breast Neoplasms |
| Intervention type | Drug |
| Interventions | cetuximab paclitaxel |
| Enrollment | 25 |
| Start date | Nov 1, 2006 |
| Completion | Sep 1, 2009 |
| First posted | Jul 19, 2006 |
| Last update posted | Jan 13, 2009 |
| Countries | Israel |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: